Abstract:A multimodal approach is demonstrated integrating high‐throughput scRNA‐seq and ST to elucidate XLRS‐specific transcriptomic signatures in genetically engineered (Rs1emR209C) mice and patient‐specific iPSC‐derived 3D‐retinal organoids harboring the patient‐specific p.R209C mutation. The most enriched disease pathway is identified and targeted therapeutically, showing synergistic efficacy when combined with AAV‐based Rs1 delivery in ameliorating XLRS phenotypes. X‐linked retinoschisis (XLRS) is an inherited retinal disorder with severe retinoschisis and visual impairments. Multiomics approaches integrate single‐cell RNA‐sequencing (scRNA‐seq) and spatiotemporal transcriptomics (ST) offering potential for dissecting transcriptional networks and revealing cell‐cell interactions involved in biomolecular pathomechanisms. Herein, a multimodal approach is demonstrated combining high‐throughput scRNA‐seq and ST to elucidate XLRS‐specific transcriptomic signatures in two XLRS‐like models with retinal splitting phenotypes, including genetically engineered (Rs1emR209C) mice and patient‐derived retinal organoids harboring the same patient‐specific p.R209C mutation. Through multiomics transcriptomic analysis, the endoplasmic reticulum (ER) stress/eukryotic initiation factor 2 (eIF2) signaling, mTOR pathway, and the regulation of eIF4 and p70S6K pathways are identified as chronically enriched and highly conserved disease pathways between two XLRS‐like models. Western blots and proteomics analysis validate the occurrence of unfolded protein responses, chronic eIF2α signaling activation, and chronic ER stress‐induced apoptosis. Furthermore, therapeutic targeting of the chronic ER stress/eIF2α pathway activation synergistically enhances the efficacy of AAV‐mediated RS1 gene delivery, ultimately improving bipolar cell integrity, postsynaptic transmission, disorganized retinal architecture, and electrophysiological responses. Collectively, the complex transcriptomic signatures obtained from Rs1emR209C mice and patient‐derived retinal organoids using the multiomics approach provide opportunities to unravel potential therapeutic targets for incurable retinal diseases, such as XLRS.

Introduction of an RS1 mutation causative variant consistent with identified XLRS patient using CRISPR/Cas9 technology in normal iPSC

Clinical Features of X Linked Juvenile Retinoschisis in Chinese Families Associated with Novel Mutations in the RS1 Gene.

Generation of an Induced Pluripotent Stem Cell Line from a Brugada Syndrome Patient Carrying SCN5A/c.3118G>C Mutation

Identifying Multiomic Signatures of X‐Linked Retinoschisis‐Derived Retinal Organoids and Mice Harboring Patient‐Specific Mutation Using Spatiotemporal Single‐Cell Transcriptomics

Dual Supramolecular Nanoparticle Vectors Enable CRISPR/Cas9‐Mediated Knockin of Retinoschisin 1 Gene—A Potential Nonviral Therapeutic Solution for X‐Linked Juvenile Retinoschisis

Retinal Proteomic Alterations and Combined Transcriptomic-Proteomic Analysis in the Early Stages of Progression of a Mouse Model of X-Linked Retinoschisis

Genetic Analysis and Clinical Features of X-linked Retinoschisis in Chinese Patients

Association of clinical features of X linked juvenile retinoschisis with new mutations in XLRS1 gene in Chinese families

Genotypic and phenotypic diversity in X-linked retinoschisis: Findings from a South Indian patient cohort

Early Developmental Characteristics and Features of a Three-Dimensional Retinal Organoid Model of X-Linked Juvenile Retinoschisis

R102w Mutation In The Rs1gene Responsible For Retinoschisis And Recurrent Glaucoma

Genetic, morphological and electrophysiological findings in a patient with a rare pathogenic variant in the RS1 gene

R213W mutation in the retinoschisis 1 gene causes X-linked juvenile retinoschisis in a large Chinese family

Generation of an induced pluripotent stem cell line (SJTUGHi001-A) from a patient with Retinitis Pigmentosa carrying c.77C > T mutation in RAX2 gene

Analysis of the New Mutations of the Gene in Chinese Patients with Congenital Retinoschisis

Identification and molecular characterization of two recurrent missense mutations in the RS1 gene in two families with X-linked retinoschisis from North India

Comprehensive analysis of genetic and clinical characteristics of 30 patients with X-linked juvenile retinoschisis in China

Gene Therapy: Dual Supramolecular Nanoparticle Vectors Enable CRISPR/Cas9‐Mediated Knockin of Retinoschisin 1 Gene—A Potential Nonviral Therapeutic Solution for X‐Linked Juvenile Retinoschisis (adv. Sci. 10/2020)

Generation of a gene-corrected isogenic human iPSC line (CSUASOi006-A-1) from a retinitis pigmentosa patient with heterozygous c.5792C > T mutation in the PRPF8 gene

Establishment of the induced pluripotent stem cell line SJTUGHi002-A from a CNGA1-related recessive retinitis pigmentosa patient

Generation of an Induced Pluripotent Stem Cell Line (Shcdnri001-A) from a Patient with X-linked Alport Syndrome Carrying a Heterozygous P.g409s (c. 1225 G > A) Mutation in the COL4A5 Gene